The Cooper Companies, Inc. (NYSE:COO) Shares Acquired by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP boosted its holdings in shares of The Cooper Companies, Inc. (NYSE:COO) by 46.7% in the 2nd quarter, Holdings Channel reports. The firm owned 39,859 shares of the medical device company’s stock after buying an additional 12,696 shares during the period. ExodusPoint Capital Management LP’s holdings in Cooper Companies were worth $15,283,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Cooper Companies by 0.3% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,367 shares of the medical device company’s stock valued at $3,124,000 after purchasing an additional 26 shares during the last quarter. Mitchell & Pahl Private Wealth LLC lifted its position in shares of Cooper Companies by 1.8% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 1,546 shares of the medical device company’s stock valued at $577,000 after acquiring an additional 27 shares in the last quarter. Venturi Wealth Management LLC lifted its position in shares of Cooper Companies by 59.3% in the 2nd quarter. Venturi Wealth Management LLC now owns 86 shares of the medical device company’s stock valued at $33,000 after acquiring an additional 32 shares in the last quarter. Lincoln National Corp lifted its position in shares of Cooper Companies by 5.1% in the 2nd quarter. Lincoln National Corp now owns 663 shares of the medical device company’s stock valued at $254,000 after acquiring an additional 32 shares in the last quarter. Finally, Private Trust Co. NA lifted its position in shares of Cooper Companies by 28.5% in the 2nd quarter. Private Trust Co. NA now owns 167 shares of the medical device company’s stock valued at $64,000 after acquiring an additional 37 shares in the last quarter. 96.31% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

NYSE:COO opened at $338.01 on Tuesday. The Cooper Companies, Inc. has a 1 year low of $302.88 and a 1 year high of $399.62. The firm’s fifty day simple moving average is $325.72 and its 200 day simple moving average is $358.50. The company has a current ratio of 1.72, a quick ratio of 0.99 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $16.74 billion, a PE ratio of 61.12, a PEG ratio of 2.69 and a beta of 0.94.

Cooper Companies (NYSE:COO) last posted its earnings results on Wednesday, August 30th. The medical device company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.34 by $0.01. Cooper Companies had a net margin of 7.83% and a return on equity of 8.17%. The business had revenue of $930.20 million for the quarter, compared to analyst estimates of $899.77 million. During the same period last year, the business posted $3.19 EPS. Cooper Companies’s revenue was up 10.3% compared to the same quarter last year. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 12.81 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently commented on COO. StockNews.com began coverage on shares of Cooper Companies in a research report on Thursday, October 5th. They issued a “hold” rating for the company. Redburn Atlantic downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and cut their target price for the stock from $390.00 to $343.00 in a research report on Thursday, October 5th. Morgan Stanley began coverage on shares of Cooper Companies in a research report on Thursday, September 28th. They issued an “equal weight” rating and a $410.00 target price for the company. Mizuho reiterated a “buy” rating and issued a $440.00 target price on shares of Cooper Companies in a research report on Monday, August 28th. Finally, Bank of America began coverage on shares of Cooper Companies in a research report on Monday, October 30th. They issued a “buy” rating and a $380.00 target price for the company. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $401.30.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.